Iridocyclitis associated with angle-supported phakic intraocular lenses
Identifieur interne : 006072 ( Main/Curation ); précédent : 006071; suivant : 006073Iridocyclitis associated with angle-supported phakic intraocular lenses
Auteurs : Antonio Leccisotti [Italie]Source :
- Journal of cataract and refractive surgery [ 0886-3350 ] ; 2006.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Association, Chirurgie.
English descriptors
- KwdEn :
- Adult, Angle, Anterior Chamber (surgery), Anti-Bacterial Agents (therapeutic use), Association, Drug Therapy, Combination, Female, Glucocorticoids (therapeutic use), Humans, Hyperopia (surgery), Incidence, Intraocular lens, Iridocyclitis, Iridocyclitis (diagnosis), Iridocyclitis (drug therapy), Iridocyclitis (etiology), Lens Implantation, Intraocular (methods), Lens, Crystalline (physiology), Lenses, Intraocular (adverse effects), Male, Middle Aged, Myopia (surgery), Odds Ratio, Ophthalmology, Prognosis, Retrospective Studies, Risk Factors, Support, Surgery, Treatment, Visual Acuity.
- MESH :
- chemical , therapeutic use : Anti-Bacterial Agents, Glucocorticoids.
- adverse effects : Lenses, Intraocular.
- diagnosis : Iridocyclitis.
- drug therapy : Iridocyclitis.
- etiology : Iridocyclitis.
- methods : Lens Implantation, Intraocular.
- physiology : Lens, Crystalline.
- surgery : Anterior Chamber, Hyperopia, Myopia.
- Adult, Drug Therapy, Combination, Female, Humans, Incidence, Male, Middle Aged, Odds Ratio, Prognosis, Retrospective Studies, Risk Factors, Visual Acuity.
Abstract
PURPOSE: To evaluate incidence, features, risk factors, and prognosis of iridocyclitis after angle-supported phakic intraocular lens (IOL) implantation. SETTING: Private practice, Siena, Italy. METHODS: This retrospective analysis comprised 356 consecutive eyes of 212 patients. In myopic eyes, the ZSAL-4 IOL (205 eyes of 125 patients) or the ZSAL-4 Plus IOL (106 eyes of 63 patients) was used. In hyperopic eyes (45 eyes of 24 patients), the Type 54 IOL was implanted. Haptic posterior angulation was 19 degrees (ZSAL-4), 23 degrees (ZSAL-4 Plus), and 14 degrees (Type 54). RESULTS: Clinically significant iridocyclitis occurred in 11 eyes (3.1%) of 11 patients. Mean patient age was 37.3 years ± 9.4 (SD). Sixty-four percent were male (odds ratio [OR], 3.0; 95% confidence interval [Cl], 0.8 to 7.4, not statistically significant). Iridocyclitis was observed in 4.4% of hyperopic eyes (OR, 1.6; 95% Cl, 0.3 to 7.4; not statistically significant) and in 2.9% of myopic eyes. In myopic eyes, it followed the implantation of ZSAL-4 IOL in 3.9% of eyes (OR, 4.1; 95% Cl, 0.5 to 33.6; not statistically significant), and of ZSAL-4 Plus IOL in 1%. Mean time from surgery was 8.5 + 10.6 months). Presentation included aqueous flare (100%), posterior synechiae (82%), blurred vision (82%), redness (36%), pain (27%), IOL precipitates (18%), and angular synechiae (9%). Only 1 patient had recurrences, leading to IOL explantation and cataract surgery. After topical therapy, best spectacle-corrected visual acuity was fully recovered in 9 of 11 eyes. CONCLUSION: Iridocyclitis can occur months or years after the implantation of angle-supported phakic lOLs. No statistically significant risk factors were identified. Functional prognosis is generally good.
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000C82
- to stream PascalFrancis, to step Curation: Pour aller vers cette notice dans l'étape Curation :000824
- to stream PascalFrancis, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000972
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :006329
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001781
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :001781
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001576
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000950
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :000950
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000950
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :005E01
Links to Exploration step
Pascal:06-0360057Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Iridocyclitis associated with angle-supported phakic intraocular lenses</title>
<author><name sortKey="Leccisotti, Antonio" sort="Leccisotti, Antonio" uniqKey="Leccisotti A" first="Antonio" last="Leccisotti">Antonio Leccisotti</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Ophthalmic Surgery Unit, Casa di Cura Rugani</s1>
<s2>Siena</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Siena</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">06-0360057</idno>
<date when="2006">2006</date>
<idno type="stanalyst">PASCAL 06-0360057 INIST</idno>
<idno type="RBID">Pascal:06-0360057</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000C82</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000824</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000972</idno>
<idno type="wicri:doubleKey">0886-3350:2006:Leccisotti A:iridocyclitis:associated:with</idno>
<idno type="wicri:Area/Main/Merge">006329</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:16814060</idno>
<idno type="wicri:Area/PubMed/Corpus">001781</idno>
<idno type="wicri:Area/PubMed/Curation">001781</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001576</idno>
<idno type="wicri:Area/Ncbi/Merge">000950</idno>
<idno type="wicri:Area/Ncbi/Curation">000950</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000950</idno>
<idno type="wicri:doubleKey">0886-3350:2006:Leccisotti A:iridocyclitis:associated:with</idno>
<idno type="wicri:Area/Main/Merge">005E01</idno>
<idno type="wicri:Area/Main/Curation">006072</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Iridocyclitis associated with angle-supported phakic intraocular lenses</title>
<author><name sortKey="Leccisotti, Antonio" sort="Leccisotti, Antonio" uniqKey="Leccisotti A" first="Antonio" last="Leccisotti">Antonio Leccisotti</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Ophthalmic Surgery Unit, Casa di Cura Rugani</s1>
<s2>Siena</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Siena</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of cataract and refractive surgery</title>
<title level="j" type="abbreviated">J. cataract refractive surg.</title>
<idno type="ISSN">0886-3350</idno>
<imprint><date when="2006">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of cataract and refractive surgery</title>
<title level="j" type="abbreviated">J. cataract refractive surg.</title>
<idno type="ISSN">0886-3350</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Angle</term>
<term>Anterior Chamber (surgery)</term>
<term>Anti-Bacterial Agents (therapeutic use)</term>
<term>Association</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Glucocorticoids (therapeutic use)</term>
<term>Humans</term>
<term>Hyperopia (surgery)</term>
<term>Incidence</term>
<term>Intraocular lens</term>
<term>Iridocyclitis</term>
<term>Iridocyclitis (diagnosis)</term>
<term>Iridocyclitis (drug therapy)</term>
<term>Iridocyclitis (etiology)</term>
<term>Lens Implantation, Intraocular (methods)</term>
<term>Lens, Crystalline (physiology)</term>
<term>Lenses, Intraocular (adverse effects)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Myopia (surgery)</term>
<term>Odds Ratio</term>
<term>Ophthalmology</term>
<term>Prognosis</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>Support</term>
<term>Surgery</term>
<term>Treatment</term>
<term>Visual Acuity</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term>
<term>Glucocorticoids</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lenses, Intraocular</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Iridocyclitis</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Iridocyclitis</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Iridocyclitis</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lens Implantation, Intraocular</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Lens, Crystalline</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Anterior Chamber</term>
<term>Hyperopia</term>
<term>Myopia</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Odds Ratio</term>
<term>Prognosis</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>Visual Acuity</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Iridocyclite</term>
<term>Association</term>
<term>Angle</term>
<term>Support</term>
<term>Lentille intraoculaire</term>
<term>Chirurgie</term>
<term>Ophtalmologie</term>
<term>Traitement</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Association</term>
<term>Chirurgie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">PURPOSE: To evaluate incidence, features, risk factors, and prognosis of iridocyclitis after angle-supported phakic intraocular lens (IOL) implantation. SETTING: Private practice, Siena, Italy. METHODS: This retrospective analysis comprised 356 consecutive eyes of 212 patients. In myopic eyes, the ZSAL-4 IOL (205 eyes of 125 patients) or the ZSAL-4 Plus IOL (106 eyes of 63 patients) was used. In hyperopic eyes (45 eyes of 24 patients), the Type 54 IOL was implanted. Haptic posterior angulation was 19 degrees (ZSAL-4), 23 degrees (ZSAL-4 Plus), and 14 degrees (Type 54). RESULTS: Clinically significant iridocyclitis occurred in 11 eyes (3.1%) of 11 patients. Mean patient age was 37.3 years ± 9.4 (SD). Sixty-four percent were male (odds ratio [OR], 3.0; 95% confidence interval [Cl], 0.8 to 7.4, not statistically significant). Iridocyclitis was observed in 4.4% of hyperopic eyes (OR, 1.6; 95% Cl, 0.3 to 7.4; not statistically significant) and in 2.9% of myopic eyes. In myopic eyes, it followed the implantation of ZSAL-4 IOL in 3.9% of eyes (OR, 4.1; 95% Cl, 0.5 to 33.6; not statistically significant), and of ZSAL-4 Plus IOL in 1%. Mean time from surgery was 8.5 + 10.6 months). Presentation included aqueous flare (100%), posterior synechiae (82%), blurred vision (82%), redness (36%), pain (27%), IOL precipitates (18%), and angular synechiae (9%). Only 1 patient had recurrences, leading to IOL explantation and cataract surgery. After topical therapy, best spectacle-corrected visual acuity was fully recovered in 9 of 11 eyes. CONCLUSION: Iridocyclitis can occur months or years after the implantation of angle-supported phakic lOLs. No statistically significant risk factors were identified. Functional prognosis is generally good.</div>
</front>
</TEI>
<double idat="0886-3350:2006:Leccisotti A:iridocyclitis:associated:with"><INIST><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Iridocyclitis associated with angle-supported phakic intraocular lenses</title>
<author><name sortKey="Leccisotti, Antonio" sort="Leccisotti, Antonio" uniqKey="Leccisotti A" first="Antonio" last="Leccisotti">Antonio Leccisotti</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Ophthalmic Surgery Unit, Casa di Cura Rugani</s1>
<s2>Siena</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Siena</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">06-0360057</idno>
<date when="2006">2006</date>
<idno type="stanalyst">PASCAL 06-0360057 INIST</idno>
<idno type="RBID">Pascal:06-0360057</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000C82</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000824</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000972</idno>
<idno type="wicri:doubleKey">0886-3350:2006:Leccisotti A:iridocyclitis:associated:with</idno>
<idno type="wicri:Area/Main/Merge">006329</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Iridocyclitis associated with angle-supported phakic intraocular lenses</title>
<author><name sortKey="Leccisotti, Antonio" sort="Leccisotti, Antonio" uniqKey="Leccisotti A" first="Antonio" last="Leccisotti">Antonio Leccisotti</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Ophthalmic Surgery Unit, Casa di Cura Rugani</s1>
<s2>Siena</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<wicri:noRegion>Siena</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of cataract and refractive surgery</title>
<title level="j" type="abbreviated">J. cataract refractive surg.</title>
<idno type="ISSN">0886-3350</idno>
<imprint><date when="2006">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of cataract and refractive surgery</title>
<title level="j" type="abbreviated">J. cataract refractive surg.</title>
<idno type="ISSN">0886-3350</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Angle</term>
<term>Association</term>
<term>Intraocular lens</term>
<term>Iridocyclitis</term>
<term>Ophthalmology</term>
<term>Support</term>
<term>Surgery</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Iridocyclite</term>
<term>Association</term>
<term>Angle</term>
<term>Support</term>
<term>Lentille intraoculaire</term>
<term>Chirurgie</term>
<term>Ophtalmologie</term>
<term>Traitement</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Association</term>
<term>Chirurgie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">PURPOSE: To evaluate incidence, features, risk factors, and prognosis of iridocyclitis after angle-supported phakic intraocular lens (IOL) implantation. SETTING: Private practice, Siena, Italy. METHODS: This retrospective analysis comprised 356 consecutive eyes of 212 patients. In myopic eyes, the ZSAL-4 IOL (205 eyes of 125 patients) or the ZSAL-4 Plus IOL (106 eyes of 63 patients) was used. In hyperopic eyes (45 eyes of 24 patients), the Type 54 IOL was implanted. Haptic posterior angulation was 19 degrees (ZSAL-4), 23 degrees (ZSAL-4 Plus), and 14 degrees (Type 54). RESULTS: Clinically significant iridocyclitis occurred in 11 eyes (3.1%) of 11 patients. Mean patient age was 37.3 years ± 9.4 (SD). Sixty-four percent were male (odds ratio [OR], 3.0; 95% confidence interval [Cl], 0.8 to 7.4, not statistically significant). Iridocyclitis was observed in 4.4% of hyperopic eyes (OR, 1.6; 95% Cl, 0.3 to 7.4; not statistically significant) and in 2.9% of myopic eyes. In myopic eyes, it followed the implantation of ZSAL-4 IOL in 3.9% of eyes (OR, 4.1; 95% Cl, 0.5 to 33.6; not statistically significant), and of ZSAL-4 Plus IOL in 1%. Mean time from surgery was 8.5 + 10.6 months). Presentation included aqueous flare (100%), posterior synechiae (82%), blurred vision (82%), redness (36%), pain (27%), IOL precipitates (18%), and angular synechiae (9%). Only 1 patient had recurrences, leading to IOL explantation and cataract surgery. After topical therapy, best spectacle-corrected visual acuity was fully recovered in 9 of 11 eyes. CONCLUSION: Iridocyclitis can occur months or years after the implantation of angle-supported phakic lOLs. No statistically significant risk factors were identified. Functional prognosis is generally good.</div>
</front>
</TEI>
</INIST>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Iridocyclitis associated with angle-supported phakic intraocular lenses.</title>
<author><name sortKey="Leccisotti, Antonio" sort="Leccisotti, Antonio" uniqKey="Leccisotti A" first="Antonio" last="Leccisotti">Antonio Leccisotti</name>
<affiliation wicri:level="1"><nlm:affiliation>Ophthalmic Surgery Unit, Casa di Cura Rugani, Siena, Italy. leccisotti@libero.it</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Ophthalmic Surgery Unit, Casa di Cura Rugani, Siena</wicri:regionArea>
<wicri:noRegion>Siena</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="doi">10.1016/j.jcrs.2006.02.030</idno>
<idno type="RBID">pubmed:16814060</idno>
<idno type="pmid">16814060</idno>
<idno type="wicri:Area/PubMed/Corpus">001781</idno>
<idno type="wicri:Area/PubMed/Curation">001781</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001576</idno>
<idno type="wicri:Area/Ncbi/Merge">000950</idno>
<idno type="wicri:Area/Ncbi/Curation">000950</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000950</idno>
<idno type="wicri:doubleKey">0886-3350:2006:Leccisotti A:iridocyclitis:associated:with</idno>
<idno type="wicri:Area/Main/Merge">005E01</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Iridocyclitis associated with angle-supported phakic intraocular lenses.</title>
<author><name sortKey="Leccisotti, Antonio" sort="Leccisotti, Antonio" uniqKey="Leccisotti A" first="Antonio" last="Leccisotti">Antonio Leccisotti</name>
<affiliation wicri:level="1"><nlm:affiliation>Ophthalmic Surgery Unit, Casa di Cura Rugani, Siena, Italy. leccisotti@libero.it</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Ophthalmic Surgery Unit, Casa di Cura Rugani, Siena</wicri:regionArea>
<wicri:noRegion>Siena</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of cataract and refractive surgery</title>
<idno type="ISSN">0886-3350</idno>
<imprint><date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Anterior Chamber (surgery)</term>
<term>Anti-Bacterial Agents (therapeutic use)</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Glucocorticoids (therapeutic use)</term>
<term>Humans</term>
<term>Hyperopia (surgery)</term>
<term>Incidence</term>
<term>Iridocyclitis (diagnosis)</term>
<term>Iridocyclitis (drug therapy)</term>
<term>Iridocyclitis (etiology)</term>
<term>Lens Implantation, Intraocular (methods)</term>
<term>Lens, Crystalline (physiology)</term>
<term>Lenses, Intraocular (adverse effects)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Myopia (surgery)</term>
<term>Odds Ratio</term>
<term>Prognosis</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>Visual Acuity</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term>
<term>Glucocorticoids</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lenses, Intraocular</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Iridocyclitis</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Iridocyclitis</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Iridocyclitis</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lens Implantation, Intraocular</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Lens, Crystalline</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Anterior Chamber</term>
<term>Hyperopia</term>
<term>Myopia</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Odds Ratio</term>
<term>Prognosis</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>Visual Acuity</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To evaluate incidence, features, risk factors, and prognosis of iridocyclitis after angle-supported phakic intraocular lens (IOL) implantation.</div>
</front>
</TEI>
</PubMed>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/HapticV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006072 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 006072 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Ticri/CIDE |area= HapticV1 |flux= Main |étape= Curation |type= RBID |clé= Pascal:06-0360057 |texte= Iridocyclitis associated with angle-supported phakic intraocular lenses }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |